Table 2.
Summary of the PBOMS that were reviewed for overall quality: Instruments that quantified bleeding, evaluated menstrual and gynecological symptoms, or evaluated AUB-related quality of life
| Name of the Instrument | Background studies*, instrument development, or instrument testing |
Studies which utilized the instrument to measure study outcome |
|---|---|---|
| Instruments that quantified bleeding (n=7) | ||
| Barr pictoral chart | -------- | (21) |
| Higham PBAC | (13) | (18, 19, 22-38) |
| Janssen pictoral | (13, 39) | (40, 41) |
| Mansfield-Voda-Jorgensen Menstrual bleeding scale | (42) | -------- |
| Menstrual pictogram (paper and computerized) | (37, 38) | -------- |
| Pad and tampon count | -------- | (43, 44) |
| Unspecified Pictoral bleeding | -------- | (45) |
| Menstrual and Gynecological symptoms (n= 23) | ||
| Bleeding Diary and bleeding patterns | (46) | (18) |
| Categorical bleeding questionnaire | -------- | (47) |
| Clinical Questionnaire | -------- | (48-54) |
| Detailed menstrual questionnaire | -------- | (55) |
| Follow-up menstrual bleeding and gynecologic questionnaire |
-------- | (29) |
| Gynecologic symptoms questionnaire | -------- | (56) |
| Individual subjective change in menstrual loss | -------- | (23) |
| Menorrhagia questionnaire | -------- | (57, 58) |
| Menstrual and gynecologic questionnaire | -------- | (59) |
| Menstrual bleeding questionnaire | -------- | (60) |
| Menstrual pattern chart and questionnaire | -------- | (61) |
| Menstrual pattern questionnaire | -------- | (62) |
| Menstrual symptoms and bleeding days | -------- | (44) |
| Menstrual symptoms and gynecologic questionnaire | -------- | (30) |
| Menstrual symptoms questionnaire | -------- | (63) |
| Menstrual symptoms questionnaire | -------- | (64) |
| Menstrual symptoms questionnaire | -------- | (65) |
| Menstrual symptoms questionnaire | -------- | (32) |
| Menstrual symptoms score | -------- | (66) |
| Menstrual variations questionnaire | -------- | (36) |
| Numeric scale rating of bleeding and symptoms | -------- | (67) |
| Questionnaire including menstrual symptoms | -------- | (45) |
| Structured clinical history questionnaire for menorrhagia |
-------- | (68) |
| Multidimensional questionnaires (both menstrual symptoms and quality of life) (n=20) | ||
| Aberdeen Menorrhagia Severity Scale | (69) | (40, 41, 69-71) |
| Dartmouth COOP QOL questionnaire supplemented with questions about menstrual bleeding |
(72) | (19) |
| Follow-up questionnaire that addressed menstrual symptoms, daily activities, and sexual functioning |
-------- | (73, 74) |
| Follow-up questionnaire that assessed gynecologic symptoms, satisfaction, anxiety, and depression, sexual activity |
(75) | (15) |
| General questionnaire (patterns of menstrual bleeding, gynecologic and unrelated symptoms, time to resume sexual activity, return to normal activity |
-------- | (76) |
| Menstrual and quality of life questionnaire | -------- | (43) |
| Menstrual bleeding and quality of life | -------- | (77) |
| Menstrual bleeding and Quality of life questionnaire | -------- | (78) |
| Menstrual Bleeding-related quality of life | (79) | (20) |
| Menstrual Experience Questionnaire (MEQ) | (10) | (10, 80) |
| Menstrual symptoms and associated quality of life | (81) | (16) |
| Menstrual symptoms and perceived inconvenience | (82) | (83) |
| Menstrual symptoms and quality of life | -------- | (31) |
| MS questionnaire | (81, 84-99) | (99, 100) |
| Multiattribute utility assessment | (101) | (60, 101) |
| Patient Generated Index | (102) | -------- |
| Post-operative menorrhagia outcomes questionnaire | (103, 104) | -------- |
| Social impact score | -------- | (66) |
| Subjective change in menstrual bleeding, quality of life, and sexual functioning |
(87, 88, 97, 105, 106) |
(18) |
| VAS menstrual symptoms and quality of life | -------- | (28) |
*
“Background information”: Many questionnaires incorporated validated scales or portions of validated questionnaires. References containing background information for questionnaire development or information on the original validated scales or questionnaires are included in this part of the table.